Roughly 16% of U.S. adults who take insulin say they didn’t take the prescribed dose last year, a new report shows.
MedCity NewsThe FDA said that one manufacturer of amphetamine mixed salts, Teva, “is experiencing ongoing intermittent manufacturing delays.”
MedCity NewsAs flu cases rise across the U.S., there are reports of increased demand for flu antivirals in some hotspot states. Are pharmacies ready for a surge?
MedCity NewsAccording to the motion, more than one third of Planned Parenthood South Atlantic’s abortion patients between July 1 and September 30, 2022 came from out of state, totalling 1,317 people. In the same time period last year, just 322 patients came from out of state for abortions.
MedCity NewsThe healthcare industry has been reported as the second most targeted industry from cyberattacks. Following the business […]
MedCity NewsThe funding was led by Bold Capital Group. Other investors of the company include Khosla Ventures, WestRiver Group and Glico. In total, Viome has raised more than $150 million.
MedCity NewsThe healthcare industry is still building software to can handle its complex and vast pricing data, so it still has a few more years to go before price transparency information actually becomes useful. Once software development cycle matures, this data can infiltrate the way providers and payers neg…
MedCity NewsGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Rating) saw a significant increase in short interest in September. As of September 30th, there was short interest totalling 12,600,000 shares, an increase of 6.4% from the September 15th total of 11,840,000 shares. Based on an average daily volume of 3,330,0…
Tasting TableAmong the various types of salt that are available for purchase, there is one that celebrity chef Wolfgang Puck singles out as worth avoiding.
Tasting TableLeader in Health Management Technology Sees Continued Adoption, Announces Funding Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing it has secured growth capital led by Refinery Ventures, with participation from repeat in…
The administration will task HHS and CMMI with testing new models that are shown to improve quality and lower costs.
Tasting TableKewpie mayo isn’t just any mayo. This Japanese import is a rich, umami addition to a recipe that adds delicious flavor to any meal.
Tasting TableSANTA MONICA, Calif.--(BUSINESS WIRE)--Oct 11, 2022--
ForbesGoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:
ForbesHispanics are more likely to develop chronic obstructive pulmonary disease (COPD) at younger ages.
ForbesDr. William Winkenwerder, a former healthcare CEO who also previously served as Assistant Secretary of Defense for Health Affairs, explains how the Covid pandemic accelerated digital transformations in healthcare and what happens next.
Forbes| October 11, 2022
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company’s business to predict how a stock will trade over the upcoming year.
The Victoria AdvocatePatients sometimes drive hundreds of miles to access specialized lung care, a growing concern as climate change sparks wildfires.
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald’s
